首页> 外文期刊>Modern Pathology >CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas
【24h】

CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas

机译:CXCR4表达与甲状腺乳头状癌的肿瘤浸润程度和BRAF状态相关

获取原文
           

摘要

Emerging evidence indicates that interactions between chemokine receptors and their ligands may have a critical role in several steps of tumor development, including tumor growth, progression, and metastasis. In this report, we retrospectively evaluated CXCR4 expression in a consecutive series of 200 papillary thyroid carcinomas. We investigated the relationship between the clinicopathological features of the tumors and mutations in the BRAF gene to verify whether overexpression of CXCR4 is linked to more aggressive behavior in thyroid tumors. CXCR4 protein expression was evaluated by immunohistochemical staining. A final staining score was calculated by adding the score representing the percentage of positive cells to the intensity score. The CXCR4 expression of each papillary thyroid carcinoma sample was normalized by calculating the z score for each final staining score. Univariate analysis was used to correlate CXCR4 expression with the papillary thyroid carcinoma variant, the degree of neoplastic infiltration, the American Joint Commission on Cancer stage, the presence of lymphocytic thyroiditis and the mutation status of the BRAF gene. Multiple regression analysis confirmed a strong association between CXCR4, BRAF mutation and the degree of neoplastic infiltration. These data clearly indicate that the chemokine receptor expression induced by oncogenic activation could be the major determinant of the local aggressiveness of neoplastic cells. In conclusion, our data indicate that CXCR4 expression and BRAF mutation status could cooperatively induce and promote a more aggressive phenotype in papillary thyroid carcinoma through several pathways and specifically increase the tumors’ spread outside of the thyroid gland.
机译:新兴证据表明趋化因子受体及其配体之间的相互作用可能在肿瘤发展的多个步骤中发挥关键作用,包括肿瘤生长,进展和转移。在本报告中,我们回顾性评估了连续200例甲状腺乳头状癌中CXCR4的表达。我们调查了肿瘤的临床病理特征与BRAF基因突变之间的关系,以验证CXCR4的过度表达是否与甲状腺肿瘤中更具侵略性的行为有关。通过免疫组织化学染色评估CXCR4蛋白表达。通过将代表阳性细胞百分比的分数与强度分数相加来计算最终的染色分数。通过计算每个最终染色分数的z分数,使每个乳头状甲状腺癌样品的CXCR4表达标准化。使用单变量分析将CXCR4表达与甲状腺乳头状癌变体,肿瘤浸润程度,美国癌症联合委员会分期,淋巴细胞性甲状腺炎的存在以及BRAF基因的突变状态相关联。多元回归分析证实了CXCR4,BRAF突变与肿瘤浸润程度之间有很强的联系。这些数据清楚地表明,由致癌激活诱导的趋化因子受体表达可能是肿瘤细胞局部侵袭性的主要决定因素。总之,我们的数据表明CXCR4表达和BRAF突变状态可以通过几种途径协同诱导和促进甲状腺乳头状癌的更具侵袭性的表型,并特别地增加了肿瘤在甲状腺外的扩散。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号